Award recordCONTRACT

CARDINAL HEALTH 414, LLC

PIID 36C24518C0161· VHA· 245-NETWORK CONTRACT OFFICE 5 (36C245)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $1,952,856 net obligations· UEI CWN9UGL3NCL9· OH

Description

EO14042-PURPOSE OF MODIFICATION: INCORPORATE FAR CLAUSE 52.223-99 & VHA SUPPLEMENTAL CONTRACT REQUIREMENTS FOR ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS. | MOD TO DECREASE OY 3

Base award description: RADIOPHARMACEUTICALS

First action · last action
2018-07-01 · 2023-06-02
Transactions
11
First transaction's obligation
$139,445
Base + all options value (sum of deltas)
$1,952,856
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325411 · MEDICINAL AND BOTANICAL MANUFACTURING

Modification chain · 11 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$3,139,445$0Base award · 2018-07-01 · this action $139,445 · running total $139,445Modification P00001 · 2018-09-27 · this action $0 · running total $139,445Modification P00002 · 2018-10-01 · this action $1,000,000 · running total $1,139,445Modification P00003 · 2019-10-01 · this action $1,000,000 · running total $2,139,445Modification P00004 · 2020-10-01 · this action $1,000,000 · running total $3,139,445Modification P00005 · 2020-12-16 · this action -$433,943 · running total $2,705,502Modification P00007 · 2021-04-19 · this action -$606,463 · running total $2,099,039Modification P00006 · 2021-04-23 · this action -$3,006 · running total $2,096,033Modification P00008 · 2021-10-01 · this action $989,692 · running total $3,085,726Modification P00010 · 2022-12-21 · this action -$520,189 · running total $2,565,537Modification P00011 · 2023-06-02 · this action -$612,681 · running total $1,952,856
  • Base2018-07-01+$139,445= $139,445
  • Mod P000012018-09-27+$0= $139,445
  • Mod P000022018-10-01+$1,000,000= $1,139,445
  • Mod P000032019-10-01+$1,000,000= $2,139,445
  • Mod P000042020-10-01+$1,000,000= $3,139,445
  • Mod P000052020-12-16-$433,943= $2,705,502
  • Mod P000072021-04-19-$606,463= $2,099,039
  • Mod P000062021-04-23-$3,006= $2,096,033
  • Mod P000082021-10-01+$989,692= $3,085,726
  • Mod P000102022-12-21-$520,189= $2,565,537
  • Mod P000112023-06-02-$612,681= $1,952,856
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-07-01+$139,445$139,445RADIOPHARMACEUTICALS
Mod P00001· OTHER ADMINISTRATIVE ACTION2018-09-27+$0$139,445RADIOPHARMACEUTICALS
Mod P00002· EXERCISE AN OPTION2018-10-01+$1,000,000$1,139,445RADIOPHARMACEUTICALS
Mod P00003· EXERCISE AN OPTION2019-10-01+$1,000,000$2,139,445RADIOPHARMACEUTICALS
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-10-01+$1,000,000$3,139,445RADIOPHARMACEUTICALS
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-12-16−$433,943$2,705,502PO 688-C90076 | MOD P00005 | DEOBLIGATE EXCESS FUNDS FROM OPTION YEAR ONE
Mod P00007· FUNDING ONLY ACTION2021-04-19−$606,463$2,099,039PO 688-C00031 | MOD P00007 | DEOBLIGATE EXCESS FUNDS FROM OPTION YEAR TWO
Mod P00006· FUNDING ONLY ACTION2021-04-23−$3,006$2,096,033REMOVE VIZAMYL MOD
Mod P00008· EXERCISE AN OPTION2021-10-01+$989,692$3,085,726RADIOPHARMACEUTICALS, EXERCISING OPTION YEAR 4
Mod P00010· FUNDING ONLY ACTION2022-12-21−$520,189$2,565,537EO14042 - PURPOSE OF MODIFICATION: TO INCORPORATE FAR CLAUSE 52.223-99 AND VHA SUPPLEMENTAL CONTRACT REQUIREM…
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-06-02−$612,681$1,952,856EO14042-PURPOSE OF MODIFICATION: INCORPORATE FAR CLAUSE 52.223-99 & VHA SUPPLEMENTAL CONTRACT REQUIREMENTS FOR…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI CWN9UGL3NCL9)

AwardOffice · PSC / listingNet obligationsFY
36C24226N0711242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY$100,008FY2026
36C24126P0328241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$999,797FY2026
36C25726N0407257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$1,400,000FY2026
36C25526N0361255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$228,679FY2026
36C24426N0938244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$650,641FY2026
36C24426D0097244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$0FY2026

Other recipients under 6505 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24526N0840TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$19,139FY2026
36C24526N0839TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$38,360FY2026
36C24526N0837QOL MEDICAL LLC245-NETWORK CONTRACT OFFICE 5 (36C245)$16,945FY2026
36C24526N0835TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$34,605FY2026
36C24526N0834GALDERMA LABORATORIES, L.P.245-NETWORK CONTRACT OFFICE 5 (36C245)$16,960FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24518C0161_3600_-NONE-_-NONE- · retrieved 2026-09-26.